Table 5.

Study results

Response per RECIST 1.1	Overall, n (%)	GI‐6301 (vaccine), n (%)	Placebo, n (%)
PD	13 (54)	5 (45)	8 (62)
SD	7 (29)	3 (27)	4 (31)
ORR (PR + CR)	2 (8)	1 (9)	1 (8)
PR	2 (8)	1 (9)	1 (8)
CR	0 (0)	0 (0)	0 (0)
Nonevaluable	2 (8)	2 (18)	0 (0)

Abbreviations: CR, complete response; ORR, overall response rate; PD, progressive disease; PR, partial response; SD, stable disease.